Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.73 and traded as high as $5.23. Cumberland Pharmaceuticals shares last traded at $4.60, with a volume of 297,831 shares traded.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on Cumberland Pharmaceuticals in a research note on Thursday, February 6th. They set a “hold” rating on the stock.

Cumberland Pharmaceuticals Stock Up 1.8 %

The firm has a 50 day simple moving average of $2.55 and a two-hundred day simple moving average of $1.73. The company has a market capitalization of $64.58 million, a PE ratio of -5.97 and a beta of 0.12. The company has a current ratio of 1.13, a quick ratio of 0.99 and a debt-to-equity ratio of 0.41.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.